Your browser doesn't support javascript.
loading
Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial.
Sirima, Sodiomon B; Ouedraogo, Alphonse; Barry, Nouhoun; Siribie, Mohamadou; Tiono, Alfred; Nébié, Issa; Konaté, Amadou; Berges, Gloria Damoaliga; Diarra, Amidou; Ouedraogo, Moussa; Bougouma, Edith C; Soulama, Issiaka; Hema, Alimatou; Datta, Shrimati; Liang, Yuanyuan; Rotrosen, Elizabeth T; Tracy, J Kathleen; Jamka, Leslie P; Oshinsky, Jennifer J; Pasetti, Marcela F; Neuzil, Kathleen M; Laurens, Matthew B.
Affiliation
  • Sirima SB; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Ouedraogo A; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Barry N; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Siribie M; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Tiono A; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Nébié I; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Konaté A; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Berges GD; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Diarra A; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Ouedraogo M; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Bougouma EC; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Soulama I; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Hema A; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
  • Datta S; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Liang Y; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Rotrosen ET; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Tracy JK; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Jamka LP; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Oshinsky JJ; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Pasetti MF; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Laurens MB; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: mlaurens@som.umaryland.edu.
Int J Infect Dis ; 108: 465-472, 2021 Jul.
Article in En | MEDLINE | ID: mdl-34082090
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polysaccharides, Bacterial / Typhoid-Paratyphoid Vaccines Type of study: Clinical_trials Limits: Female / Humans / Infant / Male Country/Region as subject: Africa Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polysaccharides, Bacterial / Typhoid-Paratyphoid Vaccines Type of study: Clinical_trials Limits: Female / Humans / Infant / Male Country/Region as subject: Africa Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2021 Document type: Article Affiliation country: Country of publication: